BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee DH, Giovannucci EL. The Obesity Paradox in Cancer: Epidemiologic Insights and Perspectives. Curr Nutr Rep. 2019;8:175-181. [PMID: 31129887 DOI: 10.1007/s13668-019-00280-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Valenzuela PL, Carrera-Bastos P, Castillo-García A, Lieberman DE, Santos-Lozano A, Lucia A. Obesity and the risk of cardiometabolic diseases. Nat Rev Cardiol 2023. [PMID: 36927772 DOI: 10.1038/s41569-023-00847-5] [Reference Citation Analysis]
2 Ahmadi MN, Inan-Eroglu E, Mishra GD, Salis A, Stamatakis E. Associations of changes in physical activity and diet with incident obesity and changes in adiposity: Longitudinal findings from the UK Biobank. Prev Med 2023;168:107435. [PMID: 36746246 DOI: 10.1016/j.ypmed.2023.107435] [Reference Citation Analysis]
3 Xu P, Wu D, Liu X. A proposed grading scheme for predicting recurrence in medullary thyroid cancer based on the Ki67 index and metastatic lymph node ratio. Endocrine 2023. [PMID: 36823341 DOI: 10.1007/s12020-023-03328-4] [Reference Citation Analysis]
4 Khan A, Welman CJ, Abed A, O'Hanlon S, Redfern A, Azim S, Lopez P, Singh F, Khattak A. Association of Computed Tomography Measures of Muscle and Adipose Tissue and Progressive Changes throughout Treatment with Clinical Endpoints in Patients with Advanced Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers (Basel) 2023;15. [PMID: 36900175 DOI: 10.3390/cancers15051382] [Reference Citation Analysis]
5 Chan DSM, Vieira R, Abar L, Aune D, Balducci K, Cariolou M, Greenwood DC, Markozannes G, Nanu N, Becerra-Tomás N, Giovannucci EL, Gunter MJ, Jackson AA, Kampman E, Lund V, Allen K, Brockton NT, Croker H, Katsikioti D, McGinley-Gieser D, Mitrou P, Wiseman M, Cross AJ, Riboli E, Clinton SK, McTiernan A, Norat T, Tsilidis KK. Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta-analysis. Int J Cancer 2023;152:572-99. [PMID: 36279884 DOI: 10.1002/ijc.34322] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Milić M, Ožvald I, Matković K, Radašević H, Nikolić M, Božičević D, Duh L, Matovinović M, Bituh M. Combined Approach: FFQ, DII, Anthropometric, Biochemical and DNA Damage Parameters in Obese with BMI ≥ 35 kg m(-2). Nutrients 2023;15. [PMID: 36839257 DOI: 10.3390/nu15040899] [Reference Citation Analysis]
7 Jin X, Qiu T, Li L, Yu R, Chen X, Li C, Proud CG, Jiang T. Pathophysiology of obesity and its associated diseases. Acta Pharmaceutica Sinica B 2023. [DOI: 10.1016/j.apsb.2023.01.012] [Reference Citation Analysis]
8 Liu CA, Liu T, Ruan GT, Ge YZ, Song MM, Xie HL, Lin SQ, Deng L, Zhang HY, Zhang Q, Shi HP. The relationship between fat distribution in central region and comorbidities in obese people: Based on NHANES 2011-2018. Front Endocrinol (Lausanne) 2023;14:1114963. [PMID: 36843589 DOI: 10.3389/fendo.2023.1114963] [Reference Citation Analysis]
9 VanderVeen BN, Cardaci TD, McDonald SJ, Madero SS, Unger CA, Bullard BM, Enos RT, Velázquez KT, Kubinak JL, Fan D, Murphy EA. Obesity reduced survival with 5-fluorouracil and did not protect against chemotherapy-induced cachexia or immune cell cytotoxicity in mice. Cancer Biol Ther 2022;23:1-15. [PMID: 35968771 DOI: 10.1080/15384047.2022.2108306] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Jiménez-Cortegana C, Hontecillas-Prieto L, García-Domínguez DJ, Zapata F, Palazón-Carrión N, Sánchez-León ML, Tami M, Pérez-Pérez A, Sánchez-Jiménez F, Vilariño-García T, de la Cruz-Merino L, Sánchez-Margalet V. Obesity and Risk for Lymphoma: Possible Role of Leptin. Int J Mol Sci 2022;23. [PMID: 36555171 DOI: 10.3390/ijms232415530] [Reference Citation Analysis]
11 Hasenberg T, König B. [Obesity from the Perspective of Surgical Oncology]. Zentralbl Chir 2022;147:574-83. [PMID: 36479653 DOI: 10.1055/a-1957-5622] [Reference Citation Analysis]
12 Hu J, Chen X, Yang J, Giovannucci E, Lee DH, Luo W, Cheng Q, Gong L, Wang Z, Li Q, Yang S. Association between fat mass and mortality: analysis of Mendelian randomization and lifestyle modification. Metabolism 2022;136:155307. [PMID: 36058288 DOI: 10.1016/j.metabol.2022.155307] [Reference Citation Analysis]
13 Spiegelberg D, Malmberg C, Tiblom Ehrsson Y, Laurell G. Higher Risk of Recurrence in Patients Treated for Head and Neck Cancer with Low BMI and Elevated Levels of C-Reactive Protein. Cancers (Basel) 2022;14:5161. [PMID: 36291945 DOI: 10.3390/cancers14205161] [Reference Citation Analysis]
14 Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam J, Kassouf W, Mitchell T, Montironi R, O'Brien T, Panebianco V, Scelo G, Shuch B, van Poppel H, Blosser CD, Psutka SP. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur Urol 2022:S0302-2838(22)02609-4. [PMID: 36100483 DOI: 10.1016/j.eururo.2022.08.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Cheng E, Kirley J, Cespedes Feliciano EM, Caan BJ. Adiposity and cancer survival: a systematic review and meta-analysis. Cancer Causes Control 2022. [PMID: 35971021 DOI: 10.1007/s10552-022-01613-7] [Reference Citation Analysis]
16 Jennings M, Burova M, Hamilton LG, Hunter E, Morden C, Pandya D, Beecham R, Moyses H, Saeed K, Afolabi PR, Calder PC, Dushianthan A, Wilkinson T, Freeman A, Burke H, Dushianthan A, Celinski M, Faust SN, Thomas GJ, Kipps C. Body mass index and clinical outcome of severe COVID-19 patients with acute hypoxic respiratory failure: Unravelling the “obesity paradox” phenomenon. Clinical Nutrition ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.07.016] [Reference Citation Analysis]
17 Yárnoz-Esquíroz P, Chopitea A, Olazarán L, Aguas-Ayesa M, Silva C, Vilalta-Lacarra A, Escalada J, Gil-Bazo I, Frühbeck G, Gómez-Ambrosi J. Impact on the Nutritional Status and Inflammation of Patients with Cancer Hospitalized after the SARS-CoV-2 Lockdown. Nutrients 2022;14. [PMID: 35807934 DOI: 10.3390/nu14132754] [Reference Citation Analysis]
18 Abdel-Rahman O, Ghosh S, Morrish D. Impact of baseline body mass index on the outcomes of patients with neuroendocrine neoplasms. J Endocrinol Invest 2022. [PMID: 35606667 DOI: 10.1007/s40618-022-01805-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Castelo-branco L, Tsourti Z, Gennatas S, Rogado J, Sekacheva M, Viñal D, Lee R, Croitoru A, Vitorino M, Khallaf S, Šušnjar S, Soewoto W, Cardeña A, Djerouni M, Rossi M, Alonso-gordoa T, Ngelangel C, Whisenant JG, Choueiri TK, Dimopoulou G, Pradervand S, Arnold D, Harrington K, Michielin O, Dafni U, Pentheroudakis G, Peters S, Romano E. COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO CoCARE). ESMO Open 2022. [DOI: 10.1016/j.esmoop.2022.100499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Liu Y, Hu H, Han Y, Li L, Li Z, Zhang L, Luo Z, Huang G, Lan Z. Body Mass Index Has a Nonlinear Association With Postoperative 30-Day Mortality in Patients Undergoing Craniotomy for Tumors in Men: An Analysis of Data From the ACS NSQIP Database. Front Endocrinol 2022;13:868968. [DOI: 10.3389/fendo.2022.868968] [Reference Citation Analysis]
21 Lee JH, Yoon YC, Kim HS, Cha MJ, Kim JH, Kim K, Kim HS. Obesity is associated with improved postoperative overall survival, independent of skeletal muscle mass in lung adenocarcinoma. J Cachexia Sarcopenia Muscle 2022;13:1076-86. [PMID: 35212195 DOI: 10.1002/jcsm.12956] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
22 Nitsche LJ, Mukherjee S, Cheruvu K, Krabak C, Rachala R, Ratnakaram K, Sharma P, Singh M, Yendamuri S. Exploring the Impact of the Obesity Paradox on Lung Cancer and Other Malignancies. Cancers 2022;14:1440. [DOI: 10.3390/cancers14061440] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
23 Brown RB. Obesity and Cancer: Potential Mediation by Dysregulated Dietary Phosphate. Obesities 2022;2:64-75. [DOI: 10.3390/obesities2010007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Dell'aquila E, Rossini D, Galletti A, Stellato M, Boccaccino A, Conca V, Germani MM, Bergamo F, Daniel F, Spagnoletti A, Provenzano L, Tomasello G, Zaniboni A, Buonadonna A, Fanchini L, Cupini S, Carlomagno C, Caponnetto S, Rapisardi S, Santini D. PROGNOSTIC AND PREDICTIVE ROLE OF BODY MASS INDEX (BMI) IN METASTATIC COLORECTAL CANCER (mCRC): A POOLED ANALISYS OF TRIBE AND TRIBE-2 STUDIES BY GONO. Clinical Colorectal Cancer 2022. [DOI: 10.1016/j.clcc.2022.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Lopez P, Newton RU, Taaffe DR, Singh F, Buffart LM, Spry N, Tang C, Saad F, Galvão DA. Associations of fat and muscle mass with overall survival in men with prostate cancer: a systematic review with meta-analysis. Prostate Cancer Prostatic Dis 2022;25:615-26. [PMID: 34420038 DOI: 10.1038/s41391-021-00442-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
26 Lee JH, Jee BA, Kim JH, Bae H, Chung JH, Song W, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM, Park SH, Kang M. Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer. Cancers (Basel) 2021;13:6345. [PMID: 34944964 DOI: 10.3390/cancers13246345] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Park YJ, Lee YM. Association among the Prevalence of Sarcopenia without Obesity, Nonsarcopenic Obesity, Sarcopenic Obesity, and Metabolic Syndrome in Cancer Survivors: Based on Korea National Health and Nutrition Examination Survey. Asia Pac J Oncol Nurs 2021;8:679-86. [PMID: 34790852 DOI: 10.4103/apjon.apjon-2116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Liu T, Li W, Zhang Y, Siyin ST, Zhang Q, Song M, Zhang K, Liu S, Shi H. Associations between hepatitis B virus infection and risk of colorectal Cancer: a population-based prospective study. BMC Cancer 2021;21:1119. [PMID: 34663268 DOI: 10.1186/s12885-021-08846-w] [Reference Citation Analysis]
29 Bobulescu IA, Pop LM, Mani C, Turner K, Rivera C, Khatoon S, Kairamkonda S, Hannan R, Palle K. Renal Lipid Metabolism Abnormalities in Obesity and Clear Cell Renal Cell Carcinoma. Metabolites 2021;11:608. [PMID: 34564424 DOI: 10.3390/metabo11090608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Clifton KK, Ma CX, Fontana L, Peterson LL. Intermittent fasting in the prevention and treatment of cancer. CA Cancer J Clin 2021. [PMID: 34383300 DOI: 10.3322/caac.21694] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
31 Li J, Simon G, Castro MR, Kumar V, Steinbach MS, Caraballo PJ. Association of BMI, comorbidities and all-cause mortality by using a baseline mortality risk model. PLoS One 2021;16:e0253696. [PMID: 34242241 DOI: 10.1371/journal.pone.0253696] [Reference Citation Analysis]
32 Lee M, Oh MS, Jung S, Lee JH, Kim CH, Jang MU, Kim YE, Bae HJ, Park J, Kang Y, Lee BC, Lim JS, Yu KH. Differential effects of body mass index on domain-specific cognitive outcomes after stroke. Sci Rep 2021;11:14168. [PMID: 34239011 DOI: 10.1038/s41598-021-93714-7] [Reference Citation Analysis]
33 Vithayathil M, Carter P, Kar S, Mason AM, Burgess S, Larsson SC. Body size and composition and risk of site-specific cancers in the UK Biobank and large international consortia: A mendelian randomisation study. PLoS Med 2021;18:e1003706. [PMID: 34324486 DOI: 10.1371/journal.pmed.1003706] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
34 Venniyoor A. Obesity-related Cancers: The Coming Epidemic. Indian Journal of Medical and Paediatric Oncology 2021;41:328-34. [DOI: 10.4103/ijmpo.ijmpo_117_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Jiménez-Cortegana C, López-Saavedra A, Sánchez-Jiménez F, Pérez-Pérez A, Castiñeiras J, Virizuela-Echaburu JA, de la Cruz-Merino L, Sánchez-Margalet V. Leptin, Both Bad and Good Actor in Cancer. Biomolecules 2021;11:913. [PMID: 34202969 DOI: 10.3390/biom11060913] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
36 Bossi P, Delrio P, Mascheroni A, Zanetti M. The Spectrum of Malnutrition/Cachexia/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review. Nutrients 2021;13:1980. [PMID: 34207529 DOI: 10.3390/nu13061980] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 16.5] [Reference Citation Analysis]
37 Hue JJ, Ufholz K, Winter JM, Markt SC. Unintentional Weight Loss as a Marker of Malignancy Across Body Weight Categories. Curr Cardiovasc Risk Rep 2021;15. [DOI: 10.1007/s12170-021-00674-8] [Reference Citation Analysis]
38 Fernandez CJ, George AS, Subrahmanyan NA, Pappachan JM. Epidemiological link between obesity, type 2 diabetes mellitus and cancer. World J Methodol 2021;11:23-45. [PMID: 34026577 DOI: 10.5662/wjm.v11.i3.23] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
39 Valente Aguiar P, Carvalho B, Vaz R, Linhares P. Body mass index as an independent prognostic factor in glioblastoma. Cancer Causes Control 2021;32:327-36. [PMID: 33447892 DOI: 10.1007/s10552-020-01388-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
40 Sanchez A, Furberg H. Understanding the obesity paradox in cancer: looking to body composition and tumor-specific biology to understand this complex association. Am J Clin Nutr 2021;113:1-2. [PMID: 33236039 DOI: 10.1093/ajcn/nqaa317] [Reference Citation Analysis]
41 Fajardo-orduña G, Chamorro-plata D. Molecular and therapeutic bases of cancer. Oncological Functional Nutrition 2021. [DOI: 10.1016/b978-0-12-819828-5.00002-4] [Reference Citation Analysis]
42 Carrasco Quintero MDR, García Villegas EA, Alfonso Baruch EE, Ledesma Solano JÁ, Aguilar Carrasco FR. Estado de nutrición y relación con patología de pacientes al ingreso hospitalario, Ciudad de México. ALAN 2020;70:115-122. [DOI: 10.37527/2020.70.2.004] [Reference Citation Analysis]
43 Rezende LFM, Lee DH, Ferrari G, Giovannucci E. Confounding due to pre-existing diseases in epidemiologic studies on sedentary behavior and all-cause mortality: a meta-epidemiologic study. Ann Epidemiol 2020;52:7-14. [PMID: 32950658 DOI: 10.1016/j.annepidem.2020.09.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
44 Correa-de-Araujo R, Addison O, Miljkovic I, Goodpaster BH, Bergman BC, Clark RV, Elena JW, Esser KA, Ferrucci L, Harris-Love MO, Kritchevsky SB, Lorbergs A, Shepherd JA, Shulman GI, Rosen CJ. Myosteatosis in the Context of Skeletal Muscle Function Deficit: An Interdisciplinary Workshop at the National Institute on Aging. Front Physiol 2020;11:963. [PMID: 32903666 DOI: 10.3389/fphys.2020.00963] [Cited by in Crossref: 96] [Cited by in F6Publishing: 100] [Article Influence: 32.0] [Reference Citation Analysis]
45 Young AC, Quach HT, Song H, Davis EJ, Moslehi JJ, Ye F, Williams GR, Johnson DB. Impact of body composition on outcomes from anti-PD1 +/- anti-CTLA-4 treatment in melanoma. J Immunother Cancer 2020;8:e000821. [PMID: 32747470 DOI: 10.1136/jitc-2020-000821] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
46 de Paula NS, Chaves GV. Percentiles for body composition parameters based on computed tomography in patients with endometrial cancer. Nutrition 2020;79-80:110873. [PMID: 32659608 DOI: 10.1016/j.nut.2020.110873] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Almendros I, Martinez-garcia MA, Farré R, Gozal D. Obesity, sleep apnea, and cancer. Int J Obes 2020;44:1653-67. [DOI: 10.1038/s41366-020-0549-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
48 Schiffl H. Obesity and the Survival of Critically Ill Patients with Acute Kidney Injury: A Paradox within the Paradox? Kidney Dis (Basel) 2020;6:13-21. [PMID: 32021870 DOI: 10.1159/000502209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
49 Zhou B, Wu D, Liu H, Du LT, Wang YS, Xu JW, Qiu FB, Hu SY, Zhan HX. Obesity and pancreatic cancer: An update of epidemiological evidence and molecular mechanisms. Pancreatology 2019;19:941-50. [PMID: 31447281 DOI: 10.1016/j.pan.2019.08.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
50 Yang X, Zhang T, Yin X, Yuan Z, Chen H, Plymoth A, Jin L, Chen X, Lu M, Ye W. Adult height, body mass index change, and body shape change in relation to esophageal squamous cell carcinoma risk: A population-based case-control study in China. Cancer Med 2019;8:5769-78. [PMID: 31369212 DOI: 10.1002/cam4.2444] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]